Clinical Trials Directory

Trials / Unknown

UnknownNCT05225493

HIV Indicator Diseases in Hospital and Primary Care

Supporting Health Care Professionals in Hospital and Primary Care to Promote Adequate HIV Risk and Indicator Condition Driven Testing in Routine Care.

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients are frequently evaluated by physicians for medical work-up of HIV indicator conditions in hospital and in primary care at the general practitioner. Testing for HIV is indicated with HIV indicator disorder but often omitted in clinical work-up. Besides the fact that HIV testing is forgotten, there are other reasons such as an underestimation of the risk of HIV in the event of indicator disorders, stigma and difficulties in discussing the test with a patient. Also and more relevant for primary care than for the hospital, practical challenges can exist for a patient to go to a laboratory, or costs are a hurdle. This project focuses on improving HIV indicator condition driven testing in different settings of the HIV epidemic, initially in the Netherlands as low HIV prevalence setting followed by an assessment of its benefit in different international settings. A specific focus will also be on the Rotterdam area in the Netherlands which has a high prevalence of undiagnosed HIV in the Netherlands. The ultimate aim is to decrease the number of undiagnosed HIV in populations, improve the 90-90-90 HIV cascade of care goals particularly its first pillar, and to help supporting the UNAIDS goal to end HIV/AIDS

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeer to peer feedbackHIV experts contact non-HIV specialised treating physicians on individual patient care to recommend HIV testing
DIAGNOSTIC_TESTHIV rapid testFree HIV rapid tests are provided to non-HIV specialised treating physicians to use in individual patient care in patients at risk of HIV

Timeline

Start date
2020-01-01
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2022-02-04
Last updated
2022-02-04

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05225493. Inclusion in this directory is not an endorsement.